UK Healthcare Gazette
SEE OTHER BRANDS

Your healthcare and wellness news from the United Kingdom

UK Healthcare Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.

Press releases published on May 2, 2025

AST Announces the Return of the IP3 for 2025 – A Unique Patent Purchase and Licensing Opportunity for Patent Owners

AST Announces the Return of the IP3 for 2025 – A Unique Patent Purchase and Licensing Opportunity for Patent Owners

AST announces its tenth annual Industry Patent Purchase and Licensing Program - IP3 2025, connecting patent owners with major global technology firms. PRINCETON, NJ, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Allied Security Trust (AST) is excited …

Hypnosis Business Virtual Summit to Take Place June 21-22, 2025, Sponsored by HypnoBiz-in-a-Box™

Hypnosis Business Virtual Summit to Take Place June 21-22, 2025, Sponsored by HypnoBiz-in-a-Box™

The Hypnosis Business Virtual Summit is a 2-day event with expert insights for hypnosis business owners, featuring presentations from top industry leaders. TAMPA, FL, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The Hypnosis Education Association ( …

GenBio Is excited to share how functional foods improve liver structure and function

GenBio Is excited to share how functional foods improve liver structure and function

Diet plays a key role in maintaining liver health ALISO VIEJO, CA, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- Functional foods improve liver structure and function Fats are an important part of the human diet as a major source of energy. Around …

Result of General Meeting

Result of General Meeting

May 2, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of …

Global Hyperpigmentation Treatment Market Set to Surpass USD 12.4 Million by 2035 reflecting a CAGR of 9.0% | FMI

Global Hyperpigmentation Treatment Market Set to Surpass USD 12.4 Million by 2035 reflecting a CAGR of 9.0% | FMI

Emerging trends in AI-based skin assessment, rising preference for plant-based solutions, and expansion of medical-grade skincare to drive 9.0% CAGR growth NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The global hyperpigmentation …

Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI

Hidradenitis Suppurativa Treatment Market Poised for Growth: Advancements in Therapeutics and Diagnostics | FMI

The expected to advance noticeably over the forecast period owing to ongoing research towards targeted biologic therapeutics and newer drug formulation. NEWARK, DE, UNITED STATES, May 2, 2025 /⁨EINPresswire.com⁩/ -- The hidradenitis suppurativa treatment …

Best Probiotics For Gut Health: Top Probiotic Supplements To Relieve IBS, Diarrhea & Constipation – Wolfson Brands (UK) Limited

Best Probiotics For Gut Health: Top Probiotic Supplements To Relieve IBS, Diarrhea & Constipation – Wolfson Brands (UK) Limited

Glasgow, May 02, 2025 (GLOBE NEWSWIRE) -- Irritable Bowel Syndrome, or IBS, affects a large number of people and can be difficult to manage. It causes ongoing discomfort in the digestive system, often showing up as stomach cramps, gas, and irregular bowel …

Best Probiotics For Vaginal Health: Top Probiotics To Treat Bacterial Vaginosis [BV] & pH Balance – WOLFSON BRANDS (UK) LIMITED

Best Probiotics For Vaginal Health: Top Probiotics To Treat Bacterial Vaginosis [BV] & pH Balance – WOLFSON BRANDS (UK) LIMITED

Glasgow, May 02, 2025 (GLOBE NEWSWIRE) -- Bacterial vaginosis or BV is a common scourge that affects most women at some point in their lives. It is a vaginal infection that invades the tissues of the vagina causing redness, soreness, extreme itching, …

EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025

EnteroBiotix to Present Results from Phase 1b trial in Liver Cirrhosis at EASL Congress 2025

Glasgow, Scotland – 2 May 2025. EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b trial evaluating EBX-102, …

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

Tokyo, Japan and Cambridge, UK, 2 May 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2025. The full report can be found here. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service